Publication
Number of items: 12.
Public
Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019)
Krishma Adatia,
Mohamed Farag,
Ying X. Gue,
Manivannan Srinivasan
and
Diana Gorog
![]()
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: An European and Asia-Pacific Expert Consensus Paper. (2022)
Diana Gorog,
Ying X. Gue,
Tze-Fan Chao,
Laurent Fauchier,
Jose Luis Ferreiro,
Kurt Huber,
Stavros V Konstantinidis,
Deirdre A Lane,
Francisco Marin,
Jonas Oldgren,
Tatjana Potpara,
Vanessa Roldan,
Andrea Rubboli,
Dirk Sibbing,
Hung-Fat Tse,
Gemma Vilahur
and
Gregory Y H Lip
![]()
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023)
Diana Gorog,
Visvesh Jeyalan,
Rafaella I. L. Markides,
Eliano P Navarese,
Young-Hoon Jeong
and
Mohamed Farag
![]()
NETs in the infarct-related coronary artery – a marker or mediator of adverse outcome? (2022)
Diana Gorog
and
Steffen Massberg
![]()
Tissue factor pathway inhibitor and interleukin-1 receptor levels in COVID-19. (2024)
Diana Gorog
and
Brijesh Patel
![]()
Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation. (2021)
Rahim Kanji,
Christophe Vandenbriele,
Deepa R.J Arachchillage,
Susanna Price
and
Diana Gorog
![]()
The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. (2020)
Hyun Kuk Kim,
Udaya S. Tantry,
Sidney C. Smith,
Myung Ho Jeong,
Seung Jung Park,
Moo Hyun Kim,
Do Sun Lim,
Eun Seok Shin,
Duk Woo Park,
Yong Huo,
Shao Liang Chen,
Zheng Bo,
Shinya Goto,
Takeshi Kimura,
Satoshi Yasuda,
Wen Jone Chen,
Mark Chan,
Daniel Aradi,
Tobias Geisler,
Diana A. Gorog,
Dirk Sibbing,
Gregory Y.H. Lip,
Dominick J. Angiolillo,
Paul A. Gurbel
and
Young Hoon Jeong
![]()
Restricted
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017)
Christos Christopoulos,
Mohamed Farag,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size. (2018)
Mohamed Farag,
Nikolaos Spinthakis,
Manivannan Srinivasan,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice. (2019)
Tobias Geisler,
Rezo Jorbenadze,
Aron-Frederik Popov,
Karin L. Mueller,
Dominik Rath,
Michal Droppa,
Juergen Schreieck,
Peter Seizer,
Robert F. Storey,
Steen D. Kristensen,
Andrea Rubboli,
Diana Gorog,
Daniel Aradi,
Dirk Sibbing,
Kurt Huber,
Meinrad Gawaz
and
Jur Ten Berg
![]()
Understanding the Effects of NOAC Combined with Antiplatelet Therapy on Clot Kinetics. (2019)
Diana Gorog
![]()
Platelet inhibition in acute coronary syndrome and PCI: Insights from the past and present. (2020)
Diana Gorog
and
Tobias Geisler
![]()